|
SCHEDULE 1 STATEMENTS OF OPERATIONS (Details) (USD $)
In Thousands, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2011
|
|
| Operating expenses: | |||
| Research and development | $ (25,994) | $ (23,739) | $ (22,086) |
| General and administrative | (8,764) | (8,573) | (8,786) |
| Selling and marketing | (2,057) | (1,281) | (1,195) |
| Total operating expenses | (36,815) | (33,593) | (32,955) |
| Loss from operations | (13,219) | (13,475) | (12,944) |
| Interest income | 12,358 | 13,240 | 12,668 |
| Loss before income taxes | 789 | (1,479) | 5,002 |
| Income tax expenses | (403) | (772) | (879) |
| Share of net income (loss) of an equity method investee | (264) | 41 | (1,113) |
| Net income (loss) | 124 | (2,202) | 3,005 |
|
Parent Company [Member]
|
|||
| Operating expenses: | |||
| Research and development | 1,017 | (944) | (1,339) |
| General and administrative | (1,626) | (2,190) | (2,269) |
| Selling and marketing | 86 | (48) | (51) |
| Total operating expenses | (523) | (3,182) | (3,659) |
| Loss from operations | (523) | (3,182) | (3,659) |
| Interest income | 1 | ||
| Loss before income taxes | (522) | (3,182) | (3,659) |
| Income tax expenses | (150) | (150) | |
| Share of net income of subsidiaries, net of taxes | (848) | (1,080) | (6,786) |
| Share of net income (loss) of an equity method investee | 202 | 50 | 28 |
| Net income (loss) | $ 124 | $ (2,202) | $ 3,005 |
| X | ||||||||||
|
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after tax of income (loss) attributable to other redeemable noncontrolling equity holder. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|